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Background: Migraine affects up to 15% of the pediatric population. Studies in adult migraineurs have shown a higher prevalence of patent 
foramen ovale (PFO) in those with aura compared to the published general population prevalence of 25%. Increasing numbers of children with 
migraine are referred for evaluation and closure of a PFO despite the absence of data in the pediatric population. The purpose of this study was to 
determine the prevalence of PFO and degree of right to left shunting in children with migraine.
Methods: Pediatric subjects aged 6 to 18 years with migraine with and without aura but without known congenital heart disease were recruited. 
Subjects were evaluated for the presence of a PFO using contrast transthoracic echocardiography (TTE) and the degree of right to left shunting using 
contrast transcranial Doppler (TcD). Echocardiographers were blinded to the type of migraine. TcD shunts were graded as small, medium, or large. 
Fisher’s exact test was used to compare the prevalence of PFO between: 1) subjects with migraine with aura (MA+) versus those without aura (MA-), 
2) MA+ and the general population (derived from published data), and 3) MA- and the general population. Mann-Whitney rank sum test was used to 
determine if TcD shunt size was associated with aura.
Results: Of the 109 subjects, 38 had migraine with aura, and 71 had no aura. The MA+ and MA- groups were similar in gender (76% female vs. 
62% female) and age (13.0 ± 2.8 yrs vs. 11.9 ± 3.0 yrs). Compared with MA- patients, MA+ patients had a higher prevalence of PFO by TTE (27% vs. 
50%, p=0.02). Compared to the general population, MA+ patients were significantly more likely to have a PFO (25% vs. 50%, p=0.0004). In contrast, 
the prevalence of PFO in MA- patients was similar to the general population (27% vs. 25%; NS). Shunt size was not associated with the presence or 
absence of aura (p=0.63).
Conclusion: Children with migraine with aura have a significantly higher prevalence of PFO than those without aura and the general population. 
These data suggest that PFO may contribute to the pathogenesis of pediatric migraine with aura and that this population may benefit from clinical 
trials to determine the efficacy of PFO closure to ameliorate migraine burden.
